Primaquine phosphate labels and packages

Primaquine phosphate
PRIMAQUINE PHOSPHATE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

PRINCIPAL DISPLAY PANEL - 26.3 mg Tablet Bottle Label

P-425 NDC 0024-1596-01 100 tablets Primaquine phosphate Tablets, USP 26.3 mg (=15 mg base)

Usual Dosage: See package insert. Dispense in tight, light-resistant container as defined in the USP/NF. Store at 25° C (77° F); excursions permitted to 15° C - 30° C (59° F - 86° F) [see USP Controlled Room Temperature].

NSN 6505-01-348-2465 Rx only

SANOFI

References

Adapted from the FDA Package Insert.